ProShares Ultra Nasdaq Biotechnology Declares Quarterly Dividend of $0.01 (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) announced a quarterly dividend on Tuesday, March 24th. Shareholders of record on Wednesday, March 25th will be given a dividend of 0.0071 per share by the exchange traded fund on Tuesday, March 31st. This represents a c) annualized dividend and a yield of 0.0%. The ex-dividend date of this dividend is Wednesday, March 25th.

ProShares Ultra Nasdaq Biotechnology Stock Performance

NASDAQ:BIB traded up $3.93 during mid-day trading on Wednesday, hitting $78.73. 13,645 shares of the company’s stock traded hands, compared to its average volume of 12,167. The company has a market cap of $82.67 million, a PE ratio of 20.68 and a beta of 1.38. The firm’s 50 day simple moving average is $83.63 and its 200 day simple moving average is $76.03. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $33.78 and a 1 year high of $90.90.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BIB. Kaizen Financial Strategies acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter valued at $424,000. Citadel Advisors LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology in the 3rd quarter valued at $307,000. Palumbo Wealth Management LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology in the 3rd quarter valued at $766,000. Laurel Wealth Advisors LLC raised its position in ProShares Ultra Nasdaq Biotechnology by 4,481.0% in the second quarter. Laurel Wealth Advisors LLC now owns 13,743 shares of the exchange traded fund’s stock valued at $630,000 after purchasing an additional 13,443 shares during the period. Finally, Franklin Resources Inc. purchased a new position in ProShares Ultra Nasdaq Biotechnology in the second quarter valued at about $32,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.